Wang Li-hui, Liu Da-yu, Chen Ying-jie, Hou Li, Wang Bo, Mao Li-min, Lu Shen
Department of Pathology, Dalian Medical University, Dalian 116027, P. R. China.
Ai Zheng. 2002 Sep;21(9):965-9.
BACKGROUND & OBJECTIVE: There is little ideal predictor available on evaluating the lymph node metastatic potential of breast carcinoma. This study was designed to determine the expression of gene products of E-cadherin (epithelial), N-cadherin (nerve), and matrix metalloproteinase-9 (MMP-9) in breast carcinoma tissue and investigate their association with the invasion and metastasis of breast carcinoma.
The authors examined the expressions of E-cadherin, N-cadherin, and MMP-9 in 72 cases of breast carcinoma(39 cases with lymph node metastasis and 33 cases without lymph node metastasis) by immunohistochemistry. Multivariable Cox proportional hazards model was used to analyze the patients' prognosis.
The average ranks of E-cadherin in lymph node metastasis group and no lymph node metastasis group were 29.19 and 45.14, respectively, with significant difference (P < 0.001). The expression of E-cadherin was correlated inversely with the metastasis of breast carcinoma. The average ranks of N-cadherin and MMP-9 were 40.04 and 42.97 in lymph node metastasis group, and 32.32 and 28.85 in no lymph node metastasis group, both with significant difference (P < 0.05), and these expressions were positively correlated with the lymph node metastasis of breast carcinoma. The patients who had high expression of E-cadherin had a longer survival time.
Expression of E-cadherin, N-cadherin, and MMP-9 are associated strongly with lymph node metastasis of breast carcinoma. These proteins are indicators of metastasis potential and prognosis of breast carcinoma.
在评估乳腺癌淋巴结转移潜能方面,几乎没有理想的预测指标。本研究旨在检测E-钙黏蛋白(上皮型)、N-钙黏蛋白(神经型)及基质金属蛋白酶-9(MMP-9)的基因产物在乳腺癌组织中的表达情况,并探讨它们与乳腺癌侵袭和转移的关系。
作者采用免疫组织化学方法检测了72例乳腺癌患者(39例有淋巴结转移,33例无淋巴结转移)组织中E-钙黏蛋白、N-钙黏蛋白和MMP-9的表达。采用多变量Cox比例风险模型分析患者的预后情况。
E-钙黏蛋白在淋巴结转移组和无淋巴结转移组中的平均秩次分别为29.19和45.14,差异有统计学意义(P < 0.001)。E-钙黏蛋白的表达与乳腺癌转移呈负相关。N-钙黏蛋白和MMP-9在淋巴结转移组中的平均秩次分别为40.04和42.97,在无淋巴结转移组中分别为32.32和28.85,差异均有统计学意义(P < 0.05),且这些表达与乳腺癌淋巴结转移呈正相关。E-钙黏蛋白高表达的患者生存时间较长。
E-钙黏蛋白、N-钙黏蛋白和MMP-9的表达与乳腺癌淋巴结转移密切相关。这些蛋白是乳腺癌转移潜能和预后的指标。